کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3341656 | 1214231 | 2015 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: The effect of a triple therapy on maternal anti-Ro/SS-A levels associated to fetal cardiac manifestations The effect of a triple therapy on maternal anti-Ro/SS-A levels associated to fetal cardiac manifestations](/preview/png/3341656.png)
ObjectiveTo evaluate the efficacy and safety of the combination of steroids, plasmapheresis and intravenous immunoglobulins (IVIG) on maternal anti Ro/SS-A antibody levels in cases of fetal cardiac involvement.Material and methodsA series of three cases of positive anti-Ro/SS-A mothers with fetuses showing mild cardiac involvement were treated with a triple therapy composed of steroids, plasmapheresis and IVIG. Maternal antibody levels were measured several times before and after the application of each cycle of therapy. The effect of the treatment on fetal cardiac manifestations was also evaluated.ResultsMaternal anti-Ro/SS-A levels significantly decreased after each cycle of either plasmapheresis or IVIG therapy. The most significant decrease occurred after the first cycle. The natural evolution of the disease was stopped by this therapy in two of these cases, signs of cardiac inflammation decrease and none of the newborns needed neonatal pacemaker.ConclusionsA triple therapy combining plasmapheresis, IVIG and glucocorticoids may stop the natural evolution of the fetal cardiac affectation in positive anti-Ro/SS-A antibody patients. Further studies are needed in order to validate clinical applications of this treatment approach.
Journal: Autoimmunity Reviews - Volume 14, Issue 5, May 2015, Pages 423–428